GALVUS

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug GALVUS contains one active pharmaceutical ingredient (API):

1 Vildagliptin UNII I6B4B2U96P - VILDAGLIPTIN

Vildagliptin enhances the sensitivity of beta cells to glucose, resulting in improved glucose-dependent insulin secretion by increasing the endogenous levels of these incretin hormones. The administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide). Read about Vildagliptin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GALVUS Tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BH02	Vildagliptin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
Discover more medicines within A10BH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 3415R
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526528901112315, 526528903115311, 526528904111212
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 649-MEE-0115
Country: EE	Ravimiamet	Identifier(s): 1316270, 1316281, 1316292, 1316304, 1316315, 1316326, 1316337, 1316348, 1316359, 1316360
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 07414003, 07414005
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 108540, 108562
Country: FR	Base de données publique des médicaments	Identifier(s): 67520378
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 134117, 196129, 374386, 379881
Country: HK	Department of Health Drug Office	Identifier(s): 57309, 63165
Country: IE	Health Products Regulatory Authority	Identifier(s): 71711
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6291
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1028704, 1028705, 1028706, 1028707, 1028708, 1028709, 1028710, 1028711, 1028712, 1028713, 1028714, 1028715, 1028716, 1028717, 1028718, 1028719, 1028720, 1056545
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 045M2007
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 85936
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12501
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100179020
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64467001, W64467002, W64467003, W64467004, W64467005, W64467006, W64467007, W64467008, W64467009, W64467010, W64467011
Country: SG	Health Sciences Authority	Identifier(s): 13407P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10283291
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504011401, 8699504012163
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/21.2/0487